All In Biotech

Drug Trial Radar · NCT05932472

Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

Last checked: Nov 20, 2026Latest source record: Feb 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 32,706 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

32,706

Planned (sponsor's estimate)

Start

Jan 15, 2024

Primary completion

Jan 15, 2027

Study completion Feb 15, 2027

Sponsor

Lead sponsor
Tor Biering-SørensenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Wide variability in the antiplatelet effects of aspirin may lead to recurrent thromboembolic events. Several pilot studies have suggested potential benefits of taking aspirin at bedtime rather than in the morning. The primary objective of this study is to examine whether aspirin administration at bedtime versus in the morning provides a superior reduction in the incidence of major adverse cardiovascular events among patients with or without established atherosclerotic cardiovascular disease, who are already taking aspirin.

Conditions

  • Atherosclerosis
  • Cardiovascular Diseases
  • Drug Effect

Interventions

  • AspirinDrug

    Aspirin at currently prescribed dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite of hospitalization for myocardial infarction, hospitalization for stroke, coronary revascularization, or cardiovascular deathTime frame: Up to 3 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte

    Hellerup, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.